- Ticker
- ABOS
- Price
- 4.08
- Stock movement up
- +0.20 (5.15%)
- Company name
- Acumen Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markedsverdi
- 166.98M
- Ent verdi
- 16.05M
- Pris/omsetning
- -
- Pris/bok
- 0.85
- Utbytte avkastning
- -
- Utbytte vekst
- -
- Vekst år
- -
- FCF-utbetaling
- -
- Etterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års avkastning
- -32.00%
- 3 års avkastning
- -
- 5 års avkastning
- -
- 10 års avkastning
- -
Sist oppdatert: 2023-03-22
The following slide deck was published by Acumen Pharmaceuticals, Inc.
27. mars 2023
iO Charts is a Seeking Alpha partner
Acumen Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ABOS) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ETCompany ParticipantsAlex Braun - Head IRDaniel O'Connell - President and Chief...
27. mars 2023
iO Charts is a Seeking Alpha partner
UTBYTTE
ABOS betaler ikke utbytte
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
27. mars 2023
iO Charts is a Seeking Alpha partner
Acumen Pharmaceuticals is an early-stage developmental concern focusing on development treatments for Alzheimer's. Click here to read ABOS' investment analysis.
26. desember 2022
iO Charts is a Seeking Alpha partner
VERDSETTELSE
Verdsettelsesforhold
Loading...
Verdsettelsesforhold-data
| Etterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Verdsettelse (Salg/Bokført verdi)
Loading...
Verdsettelse (Salg/Bokført verdi) data
| Pris til omsetning | - |
| Pris til bok | 0.85 |
| EV i forhold til salg | - |
Acumen Pharmaceuticals (ABOS) Q3 2022 Earnings Conference Call Nov 14, 2022 04:30 PM ET
15. november 2022
iO Charts is a Seeking Alpha partner
The following slide deck was published by Acumen Pharmaceuticals, Inc.
14. november 2022
iO Charts is a Seeking Alpha partner
ØKONOMI
Per aksje
Loading...
Per aksje-data
| Gjeldende aksje antall | 40.93M |
| EPS (TTM) | -0.95 |
| FCF per aksje (TTM) | -0.69 |
Resultatregnskap
Loading...
Resultatregnskap-data
| Inntekter (TTM) | 0.00 |
| Bruttofortjeneste (TTM) | 0.00 |
| Driftsinntekter (TTM) | -39.40M |
| Netto inntekt (TTM) | -38.34M |
| EPS (TTM) | -0.95 |
| EPS (1 år fremover) | -1.22 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | - |
| Driftsmargin (TTM) | - |
| Fortjenestemargin (TTM) | - |
Balanse
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
| Kontanter | 157.54M |
| Netto fordringer | 121.00K |
| Samlede omløpsmidler | 202.56M |
| Goodwill | 0.00 |
| Immaterielle eiendeler | 0.00 |
| Eiendom, anlegg og utstyr | 0.00 |
| Sum eiendeler | 203.26M |
| Leverandørgjeld | 2.08M |
| Kortsiktig/nåværende langsiktig gjeld | 133.00K |
| Sum kortsiktig gjeld | 6.61M |
| Sum gjeld | 6.61M |
| Aksjonærenes egenkapital | 196.65M |
| Netto varige driftsmidler | 196.65M |
Kontantstrøm
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
| Kontantstrøm fra drift (TTM) | -27.59M |
| Kapitalutgifter (TTM) | 158.00K |
| Fri kontantstrøm (TTM) | -27.75M |
| Utbetalt utbytte (TTM) | 0.00 |
Finansielle inntekter
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
| Egenkapitalavkastning | -19.50% |
| Avkastning på eiendeler | -18.86% |
| Avkastning på investert kapital | -19.48% |
| Kontantavkastning på investert kapital | -14.10% |
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
14. november 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
24. oktober 2022
iO Charts is a Seeking Alpha partner
AKSJEINFORMASJON
Aksjediagram
Loading...
Aksjekurs-data
| Åpning | 3.96 |
| Daglig høy | 4.19 |
| Daglig lav | 3.90 |
| Daglig volum | 53K |
| Tidenes høyeste | 20.28 |
| 1 år analytikerestimat | 15.83 |
| Beta | - |
| EPS (TTM) | -0.95 |
| Utbytte per aksje | - |
| Ex-div dato | - |
| Neste dato for resultatpresentasjon | 27 Mar 2023 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ABOS | S&P500 | |
| Nåværende prisfall fra toppnotering | -79.88% | -17.92% |
| Høyeste prisfall | -84.81% | -56.47% |
| Dato for høyeste fall | 11 May 2022 | 9 Mar 2009 |
| Gj.snittlig fall fra topp | -61.23% | -11.51% |
| Gj.snittlig tid til ny topp | 434 days | 13 days |
| Maks tid til ny topp | 433 days | 1805 days |
Acumen's share price more than doubled because of the Eisai news on lecanemab. Here's why I think ABOS' stock price is unsustainable.
30. september 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
28. september 2022
iO Charts is a Seeking Alpha partner
SELSKAPSOPPLYSNINGER
Markedsverdi
166.98M
Markedsverdi kategori
Small-cap
Beskrivelse
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Ansatte
14
Nettsted
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
USA
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
Acumen Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ABOS) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ETCompany ParticipantsJohn Woolford - Investor Relations, WestwickeDaniel...
16. august 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
15. august 2022
iO Charts is a Seeking Alpha partner
FORSTÅ VIRKSOMHETEN
Loading...
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week
30. juli 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
30. juni 2022
iO Charts is a Seeking Alpha partner
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2022 Earnings Call Transcript March 27, 2023 Operator: Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2022 Conference Call and Web...
29. mars 2023
Data describe induced pluripotent stem cell (iPSC)-derived excitatory neurons as a human model for assessing selectivity of drug binding to soluble amyloid beta oligomers in Alzheimer’s diseaseResults...
28. mars 2023
INTERCEPT-AD, a Phase 1 clinical trial of ACU193 in patients with early Alzheimer’s disease, completed enrollment in February 2023 Topline data expected in the third quarter of 2023 Cash, cash equival...
27. mars 2023
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 22, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that ta...
22. mars 2023
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 20, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical developing a novel therapeutic that targets to...
20. mars 2023
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 08, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that ta...
8. mars 2023
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
15. februar 2023
Topline results including safety and proof-of-mechanism data expected in third quarter of 2023CHARLOTTESVILLE, Va. and CARMEL, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NAS...
13. februar 2023
Here is how Novo Nordisk (NVO) and Acumen Pharmaceuticals, Inc. (ABOS) have performed compared to their sector so far this year.
6. januar 2023
CHARLOTTESVILLE, Va. and CARMEL, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
4. januar 2023
Neste side
Acumen Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ABOS) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ETCompany ParticipantsJohn Woolford - IR, WestwickeDaniel O'Connell - President &...
17. mai 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
16. mai 2022
iO Charts is a Seeking Alpha partner